Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 13.208 | 99 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 13.0775 | 99 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 13.1876 | 99 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 13.1354 | 99 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 12.9798 | 99 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 13.2873 | 99 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 13.1664 | 99 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 13.0497 | 99 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 13.1631 | 99 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 13.2128 | 99 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 13.2701 | 99 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 13.1524 | 99 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 13.065 | 99 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 13.1052 | 99 |